Archives

FDA in the U.S. Sanctions Single-Use Gene Treatment BEQVEZ™ (fidanacogene elaparvovec-dzkt) by Pfizer for Adult Hemophilia B Patients.

Detailed illustration of a microscopic view of BEQVEZ™ (fidanacogene elaparvovec-dzkt) gene therapy targeting and repairing defective genes in a patient with Hemophilia B, with the FDA approval seal in the background.

U.S. FDA Approves Pfizer’s BEQVEZ™ for Hemophilia B The U.S. Food and Drug Administration (FDA) has granted approval to BEQVEZ™ (fidanacogene elaparvovec-dzkt), a groundbreaking one-time gene therapy developed by Pfizer Inc. for adult patients with Hemophilia B. This marks a significant advancement in the treatment landscape for individuals living with this inherited bleeding disorder. A […]

STAT+: Galapagos Embarks on Transformation, Partners to Produce CAR-T Therapies at U.S. Blood Centers

An illustration depicting a futuristic Galapagos facility with advanced laboratories and equipment, collaborating with blood centers across the United States to produce innovative CAR-T cell therapies.

Galapagos Embarks on Strategic Shift with CAR-T Therapy Production Partnership Across U.S. Blood Centers In a significant pivot aimed at bolstering its position within the dynamic biopharmaceutical landscape, Galapagos NV has announced a groundbreaking initiative to manufacture CAR-T therapies by collaborating with blood centers across the United States. This innovative approach marks a substantial transformation […]

Eisai establishes new sales goal for its Alzheimer’s medication Leqembi.

A futuristic medical research laboratory with scientists celebrating the successful development of Leqembi, a breakthrough Alzheimer’s drug, with a digital revenue target graph displaying exponential growth in the background.

Eisai Sets New Revenue Target for Alzheimer’s Drug Leqembi In an ambitious move, the Japanese pharmaceutical giant Eisai has announced a revised revenue target for Leqembi, its highly anticipated Alzheimer’s drug. This new financial forecast comes amidst growing optimism within the medical community about Leqembi’s potential in altering the treatment landscape for Alzheimer’s disease, a […]

NASA names inaugural head of AI division amid growing significance of the technology.

An illustration of a futuristic NASA control room with AI interfaces and holographic technology, featuring the first chief AI officer overseeing operations.

NASA Appoints First Chief AI Officer as the Technology’s Importance Rises In a landmark move underscoring the increasing significance of artificial intelligence (AI) across various sectors, NASA has announced the appointment of its first Chief AI Officer (CAIO). This pioneering decision reflects the agency’s commitment to integrating AI technologies into its operations, missions, and research […]

STAT+: Legislator Charges Amgen with Prioritizing Profits Over Patient Well-being Through Cancer Drug Dosage.

An illustration of a large pharmaceutical company building labeled 'Amgen' casting a shadow over a group of patients, with a symbolic representation of a cancer drug in the foreground, emphasizing the theme of profits versus patient care.

Lawmaker Accuses Amgen of Prioritizing Profits Over Patients in Cancer Drug Dosing Controversy In a recent development that has stirred significant debate within the pharmaceutical industry, a prominent lawmaker has levied serious accusations against Amgen, one of the leading biotechnology firms. The allegation? That the company has deliberately favored profit motives over patient well-being in […]

Bayer outlines job cuts amid ongoing corporate restructuring.

a minimalist illustration of a large corporate office building with scattered empty desks and a few employees packing their belongings into boxes, with the Bayer logo subtly integrated into the sky background

Bayer Details Layoffs as Company Shake-Up Continues In a decisive move that signifies a major reorganization within Bayer AG, the German multinational pharmaceutical and life sciences company has officially announced a comprehensive plan to reduce its workforce. This development is part of an ongoing strategic overhaul aimed at enhancing operational efficiency and focusing on core […]

US Government Enters the Race to Acquire AI Talent.

Concept art of futuristic government facility training AI specialists in a cybernetic classroom, with diverse individuals working on advanced computer systems and holographic projections of AI technology, symbolizing the US government entering the race to acquire AI talent.

The U.S. Government Joins the Race to Acquire AI Talent In an era where Artificial Intelligence (AI) is reshaping industries, national security, and even the global balance of power, the United States Government has officially entered the competition to attract and retain AI professionals. This strategic move underscores the importance of AI in propelling economic […]

Genetic variation prevalent in individuals of West African descent linked to high rates of heart disease.

An artistic depiction of human DNA strands intertwining with symbolic heart shapes, set against a background of a map highlighting West Africa, showcasing the link between genetic variants and cardiovascular health.

Emerging Research Identifies Genetic Variant Linked to Cardiovascular Diseases in West African Descendants Recent studies have uncovered significant findings regarding the genetic predispositions for cardiovascular diseases (CVDs) among individuals of West African descent. Researchers have pinpointed a specific genetic variant that poses a heightened risk for developing CVDs in this demographic, highlighting a critical need […]

Takeda acquires option to license Alzheimer’s immunotherapies from AC Immune.

Detailed illustration of a handshake between Takeda and AC Immune executives in front of a background depicting Alzheimer's immunotherapy research.

Takeda Pharmaceuticals Enhances Neurology Portfolio with Strategic Deal with AC Immune on Alzheimer’s Immunotherapies In a significant move that underscores the growing emphasis on innovative treatments for Alzheimer’s disease, Takeda Pharmaceutical Company Limited has secured an exclusive option to license world rights for certain therapeutic candidates from AC Immune SA, a leader in neurodegenerative disease […]